Physician profile
Christopher M Morgan
NPI 1942501002
$15,911.08
in general payments reported to CMS, 2019-2025
32 companies · $2,266 in 2025
The $2,266 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,299 · 2020: $877 · 2021: $1,382 · 2022: $2,717 · 2023: $2,575 · 2024: $2,796 · 2025: $2,266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,553 · Education: $84.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,552.99 |
| Education | $84.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $5,398.26 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic, INC. | $3,184.65 | 2021-2025 | Resolute Onyx, Corevalve Evolut R, Symplicity G3 |
| Boston Scientific Corporation | $813.57 | 2019-2025 | Avvigo Guidance System, Rotablator Rotational Atherectomy System Console Kit, Watchman Flx |
| Shockwave Medical, INC | $730.67 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $720.98 | 2019-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $716.76 | 2019-2025 | Eliquis, Camzyos |
| Abbott Laboratories | $631.18 | 2019-2025 | Aveir, Jot Dx, Ensite |
| Astrazeneca Pharmaceuticals LP | $595.37 | 2019-2025 | Farxiga, Wainua |
| Janssen Pharmaceuticals, INC | $449.64 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $367.84 | 2019-2025 | Lifevest |
| Heartflow, INC. | $339.59 | 2023-2025 | Ffrct |
| Medtronic Vascular, INC. | $335.48 | 2019-2020 | |
| Novo Nordisk INC | $217.32 | 2024-2025 | Wegovy, Ozempic |
| Amgen INC. | $194.01 | 2019-2023 | Repatha |
| Inari Medical, INC. | $175.58 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $150.74 | 2019-2025 | |
| Esperion Therapeutics, INC. | $119.43 | 2020 | |
| W. L. Gore & Associates, INC. | $109.60 | 2020-2022 | |
| Amarin Pharma, INC. | $106.24 | 2020 | |
| Lantheus Medical Imaging, INC. | $88.73 | 2020 | |
| Pfizer INC. | $85.90 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $81.48 | 2025 | Uptravi, Opsumit |
| Alnylam Pharmaceuticals INC. | $73.58 | 2024-2025 | Onpattro |
| Kiniksa Pharmaceuticals, LTD. | $39.29 | 2023 | Arcalyst |
| Scpharmaceuticals INC. | $38.13 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.92 | 2025 | |
| Sanofi-Aventis U.S. LLC | $34.83 | 2019-2020 | |
| Irhythm Technologies, INC. | $22.18 | 2024 | Zio Xt Patch, Zio Monitor |
| Philips North America LLC | $15.19 | 2025 | Coronary Other |
| Acist Medical Systems, INC. | $14.22 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $14.15 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $11.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.